Day 1: Top Takeaways From ASCO24

Day 1: Top Takeaways From ASCO24

AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)

Up next

Immunotherapy Highlights From ASCO26: Cellular Therapy, Melanoma, and Skin Cancers

Dr. Pauline Funchain and Dr. Allison Betof discuss practice-changing and paradigm-shifting abstracts in melanoma, Merkel cell carcinoma, and cellular therapies that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT 

 . 29min 43sec
GI Cancer Highlights From ASCO26: RASolute-302, BREAKWATER, and More

Dr. Nilo Azad and Dr. Aparna Parikh discuss high-impact studies in gastrointestinal cancers and other novel treatment approaches that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT 

 . 22min 46sec

Recommended Episodes

Review of the GISSI-2 Trial
Cardiology Trials

Lancet 1990;336:65-71.

Background Large trials up to this point had established the role of thr ...

  Show more

 . 10min 3sec
Review of the MIRACL Trial
Cardiology Trials

JAMA 2001;285:1711-18.

Background Statin therapy had been shown to impr ...

  Show more

 . 11min 1sec
363. GLP-1 Agonists: Diving into the Data with Dr. Darren McGuire
Cardionerds: A Cardiology Podcast

Welcome back to the CardioNerds Cardiovascular Prevention Series, where we are continuing our discussion of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs). This class of medications is becoming a household name, not only for their implications for weight loss but also for ...  Show more

 . 43min 1sec
Podcast 831: O2 Targets
Emergency Medical Minute

Contributor: Aaron Lessen,MD

Educational Pearls:

<ul> <li style="font-weight: 400;" aria-level="1"><span style= "font-weight: 400;">R</span><span style="font-weight: 400;">ecent study looked at mechanically ventilated patients in ED ...  Show more

 . 3min 19sec